Seoul, South Korea

Won Jun Hong

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Stemlab Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Won Jun Hong. Retrieved from https://idiyas.com/inventor/won-jun-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Won Jun Hong in Neural Stem Cell Research

Introduction

Won Jun Hong is an innovative inventor based in Seoul, South Korea. He has made significant contributions to the field of regenerative medicine, particularly in the area of neural stem cell research. His work focuses on the reprogramming of urine cells into neural stem cells, which has potential applications in treating neurological damage diseases.

Latest Patents

Won Jun Hong holds a patent for a groundbreaking method titled "Method for direct reprogramming of urine cells into neural stem cells using synthetic mRNA." This method involves inducing the reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1. The patent also discloses a composition for the prevention or treatment of neurological damage diseases, utilizing the neural stem cells induced by this innovative method as an active ingredient.

Career Highlights

Currently, Won Jun Hong is associated with Stemlab Inc., where he continues to advance his research in stem cell technology. His work has garnered attention for its potential to revolutionize treatments for various neurological conditions.

Collaborations

He collaborates with notable colleagues, including Seung Kwon You and Phil Jun Kang, who contribute to the research and development efforts at Stemlab Inc.

Conclusion

Won Jun Hong's innovative approach to reprogramming urine cells into neural stem cells represents a significant advancement in regenerative medicine. His contributions have the potential to lead to new therapies for neurological damage diseases, showcasing the importance of innovation in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…